Fig. 1From: Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary diseaseThe eFlow® CS (Magnair®) nebulizer systemBack to article page